Company / Interest Expense
X4 Pharmaceuticals, Inc Interest Expense History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.7M
FY2022
5-year range
$720.0K / $2.7M
FY2018-FY2022
Trend
+25.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $720,000 to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2022.
Increased from $720,000 to $3M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, interest expense increased 25.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2022 | $2.7M | +25.2% |
| FY2021 | $2.1M | +198.2% |
| FY2020 | $720.0K | -71.4% |
| FY2018 | $2.5M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026